Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of JNT-517 in phenylketonuria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• JNT-517

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Phenylketonuria | Phase 3 | Status: RECRUITING